The AML14 and AML14.3D10 cell lines: A long-overdue model for the study of eosinophils and more

Stem Cells

Volumn 16, Issue 1, 1998, Pages 16-24

  Baumann, Michael A ^a,b   Paul, Cassandra C ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell line; Differentiation; Eosinophil; Leukemia; Macrophage; Neutrophil

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

BONE MARROW CELL; CELL CLONE; CELL LINEAGE; EOSINOPHIL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; REVIEW;

EID: 0031934258     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.160016     Document Type: Review

References (39)

1. Collins SJ. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 1987;70:1233-1244.
2. Harris P, Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol 1985;37:407-422.
3. Lanotte M, Martin-Thouvenin V, Najman S et al. NB4, a maturation inducible cell line with T(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991;77:1080-1086.
4. Chen YZ, Gu XF, Caen JP et al. Interleukin-3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG-01 cells. Br J Haematol 1994;88:481-487.
5. Kobayashi S, Teramura M, Sugawara I et al. Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. Blood 1993;81:889-893.
6. Villeval J-L, Mitjavila MT, Dusanter-Fourt I et al. Autocrine stimulation by erythropoietin (Epo) requires Epo secretion. Blood 1994;84:2649-2662.
7. Hansel TT, Pound JD, Pilling D et al. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Meth 1989;122:97-103.
8. Fischkoff SA. Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions. Leuk Res 1988;12:679-686.
9. Fabian I, Lass M, Kletter Y et al. Differentiation and functional activity of human eosinophilic cells from an eosinophil HL-60 subline: response to recombinant hematopoietic growth factors. Blood 1992;80:788-794.
10. Tomonaga M, Gasson JC, Quan SG et al. Establishment of eosinophilic sublines from human promyelocytic leukemia (HL-60) cells: demonstration of multipotentiality and single-lineage commitment of HL-60 stem cells. Blood 1986;67:1433-1436.
11. Miyajima A, Mui ALF, Ogorochi T et al. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 1993;82:1960-1974.
12. Paul CC, Tolbert M, Mahrer S et al. Cooperative effects of interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor: a new myeloid cell line inducible to eosinophils. Blood 1993;81:1193-1199.
13. Paul CC, Ackerman SJ, Mahrer S et al. Cytokine induction of granule protein synthesis in an eosinophil-inducible human myeloid cell line, AML14. J Leukoc Biol 1994;56:74-79.
14. Paul CC, Mahrer S, Tolbert M et al. Changing the differentiation program of hematopoietic cells: retinoic acid-induced shift of eosinophil-committed cells to neutrophils. Blood 1995;86:3737-3744.
15. Lui PP, Hajra A, Wijmenga C et al. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995;85:2289-2302.
16. Ema H, Kitano K, Suda T et al. In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(Q22;Q22). Blood 1990;75:350-356.
17. Nucifora G, Birn DJ, Erickson P et al. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion MRNA in patients with T(8;21) acute myeloid leukemia. Blood 1993;81:883-888.
18. Hébert J, Cayulea J-M, Daniel M-T et al. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification. Blood 1994;84:2291-2296.
19. Ovsyannikova IG, Paul CC, Loegering DA et al. Processing of the proform of eosinophil granule major basic protein (MBP) to the mature form by an eosinophil-like cell line. J Allerg Clin Immunol 1997;99(suppl 1):354a.
20. Leonidas DD, Elbert B, Zhou Z et al. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase. identifies it as a new member of the carbohydrate-binding family of galectins. Structure 1995;3:1379-1393.
21. Sun Z, Yergeau DA, Tuypens T et al. Identification and characterization of a functional promoter region in the human eosinophil EL-5 receptor a subunit gene. J Biol Chem 1995;270:1462-1471.
22. Sun Z, Yergeau DA, Wong IC et al. Interleukin-5 receptor α subunit gene regulation in human eosinophil development: identification of a unique cis-element that acts like an enhancer in regulating activity of the IL-5Rα promoter. In: Wolf L, Perkins AS, eds. Molecular Aspects of Myeloid Stem Cell Development (Current Topics in Microbiology and Immunology). Berlin: Springer, 1996:173-187.
23. Sun Z, Yergeau DA, Yamaguchi Y et al. Identification of a nuclear factor in eosinophil and myeloid leukemic lines that binds to functional promoter regions of the human eosinophil peroxidase gene. Blood 1994;84(suppl 1):134a.
24. Sun Z, Wong IC, Yergeau DA et al. An enhancer-like element, CTTCCT (a PEA3, ETS-type consensus sequence) regulates transcription of the gene encoding human Charcot-Leyden crystal protein. Blood 1995;86(suppl 1):31a.
25. Ebisawa M, Yamada T, Bickel C et al. Eosinophil transendothelial migration induced by cytokines: III. Effect of the chemokine RANTES. J Immunol 1994;153:2153-2160.
26. Meurer R, Van Riper G, Feeney W et al. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1α, or human interleukin 8. J Exp Med 1993;178:1913-1921.
27. Jose PJ, Griffiths-Johnson DA, Collins PD et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-887.
28. Daugherty BL, Siciliano SJ, DeMartino JA et al. Cloning, expression and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996;183:2349-2354.
29. Mabry M, Nelkin BD, Falco JP et al. Transitions between lung cancer phenotypes - implications for tumor progression. Cancer Cells 1991;3:53-58.
30. Khanna-Gupta A, Kolibaba K, Zibello TA et al. NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. Blood 1994;84:294-302.
31. Becker PS, Potselueva T, Madri JA et al. Laminin promotes differentiation of NB4 promyelocytic leukemia cells with all-trans retinoic acid. Blood 1996;88:261-267.
32. Paul CC, McMannama K, Mahrer S et al. Autocrine activation of the IL-3/GM-CSF/IL-5 signaling pathway in leukemic cells. Am J Hematol 1997;56:79-85.
33. Young DC, Griffin JD. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 1986;68:1178-1181.
34. Murohashi I, Tohda S, Suzuki T et al. Autocrine growth mechanisms of the progenitors of blast cells in acute myeloblastic leukemia. Blood 1989;74:35-41.
35. Metcalf D. The roles of stem cell self-renewal and autocrine growth factor production in the biology of myeloid leukemia. Cancer Res 1989;49:2305-2311.
36. Moqbel R, Hamid Q, Ying S et al. Expression of MRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 1991;174:749-752.
37. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage colony-stimulating factor MRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-1424.
38. Kita H, Ohnishi T, Okubo Y et al. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils. J Exp Med 1991;174:745-748.
39. Levi-Schaffer F, Lacy P, Severs NJ et al. Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 1995;85:2579-2586.